Tenax Therapeutics shares are trading higher after the company announced that it will present results from the Phase 3 LEVEL clinical trial
Tenax Therapeutics shares are trading higher after the company announced that it will present results from the Phase 3 LEVEL clinical trial in a Late-Breaking Clinical Science session at the European Society of Cardiology Congress 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.